EcoDrugPlus

Amyloid P Component, Serum

Ensembl ID : ENSMAUG00000011083
Gene Symbol: APCS
4 Cross references
440 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSMAUG00000002042
Gene Symbol: APP
3 Cross references
276 Possible Orthologues:

Anaplastic Lymphoma Kinase

Ensembl ID : ENSMAUG00000009727
Gene Symbol: ALK
1 Cross references
194 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSMAUG00000001501
Gene Symbol: AR
4 Cross references
277 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSMAUG00000011096
Gene Symbol: AGTR1
4 Cross references
195 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSMAUG00000000833
Gene Symbol: AGTR2
4 Cross references
191 Possible Orthologues:

Angiotensin-Converting Enzyme-Like

Ensembl ID : ENSMAUG00000015310
Gene Symbol: LOC101824864
3 Cross references
93 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSMAUG00000001352
Gene Symbol: APLNR
4 Cross references
171 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSMAUG00000009007
Gene Symbol: APH1A
4 Cross references
137 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSMAUG00000013994
Gene Symbol: APEX1
4 Cross references
212 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s-Type

Ensembl ID : ENSMAUG00000021600
Gene Symbol: LOC101844629
4 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSMAUG00000018983
Gene Symbol: ALOX5
2 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).